• Science & Technology
• Health & Medicine

News digest – diagnosis delays, cervical cancer deaths, ‘what is cancer?’, and… mobile phones?

Our top stories this week include evidence of delays to cancer diagnosis, as well as the most googled health question of the year. Our top stories this week include evidence of delays to cancer diagnosis, as well as the most googled health question of the year.

23 December 2017

• Policy & Insight

Our 2017 cancer policy highlights: local, national and international

Our policy work stretches from local councils right up to the European stage. Here are our highlights from a busy 2017. Our policy work stretches from local councils right up to the European stage. Here are our highlights from a busy 2017.

21 December 2017

• Science & Technology
• Health & Medicine

2017 cancer research highlights: a patient's pick

Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him. Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him.

20 December 2017

• Health & Medicine

Cutting cancer diagnosis delays means understanding each patient’s journey

GPs say that more than 1 in 5 cancer patients in England experience an avoidable delay in their diagnosis. GPs say that more than 1 in 5 cancer patients in England experience an avoidable delay in their diagnosis.

19 December 2017

• Science & Technology

Electronic cap treatment improves brain tumour survival

Applying low frequency electric fields to the scalp of people with an aggressive type of brain tumour improves survival, according to a clinical trial. Applying low frequency electric fields to the scalp of people with an aggressive type of brain tumour improves survival, according to a clinical trial.

19 December 2017

• Science & Technology
• Health & Medicine

News digest – health warning on cigarettes, nanoparticles, ‘heat-not-burn’ tobacco and…. artificial intelligence?

This week’s news features health warning on cigarettes and long-term results from a trial testing engineered immune cells in aggressive lymphoma. This week’s news features health warning on cigarettes and long-term results from a trial testing engineered immune cells in aggressive lymphoma.

16 December 2017

• Science & Technology

Cancer Research UK announces drug discovery collaboration with Celgene Corporation

Cancer Research UK announces the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology, and Celgene Corporation Cancer Research UK announces the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology, and Celgene Corporation

15 December 2017

• Health & Medicine

Immune cell therapy results are 'landmark moment' in lymphoma treatment

Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results. Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results.

12 December 2017

• Health & Medicine

Health warnings on cigarettes could deter young people

Young people are less likely to try cigarettes with the printed health warning ‘Smoking kills’ on each stick than standard cigarettes. Young people are less likely to try cigarettes with the printed health warning ‘Smoking kills’ on each stick than standard cigarettes.

12 December 2017

• Science & Technology
• Health & Medicine

News digest – fixing NHS staff shortages, childhood obesity, a ‘ground-breaking’ trial and… British bangers?

This week’s news features a promise of over 5000 extra staff to tackle NHS shortages, and a ground-breaking personalised medicine trial for pancreatic cancer. This week’s news features a promise of over 5000 extra staff to tackle NHS shortages, and a ground-breaking personalised medicine trial for pancreatic cancer.

9 December 2017

• Health & Medicine

Breast cancer less likely to come back with more intensive chemo

Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results. Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results.

8 December 2017